| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 173.93B | 170.29B | 173.88B | 174.84B | 126.96B | 118.16B |
| Gross Profit | 54.64B | 50.37B | 49.09B | 44.94B | 37.00B | 34.29B |
| EBITDA | 33.31B | 29.81B | 30.28B | 27.77B | 21.25B | 19.97B |
| Net Income | 12.46B | 10.40B | 11.63B | 9.96B | 5.24B | 4.29B |
Balance Sheet | ||||||
| Total Assets | 195.22B | 197.84B | 188.36B | 185.37B | 161.88B | 152.54B |
| Cash, Cash Equivalents and Short-Term Investments | 8.79B | 11.32B | 9.47B | 2.72B | 9.57B | 6.14B |
| Total Debt | 58.36B | 51.66B | 62.73B | 68.09B | 58.81B | 69.75B |
| Total Liabilities | 101.57B | 109.35B | 109.35B | 117.37B | 102.68B | 98.30B |
| Stockholders Equity | 91.39B | 86.35B | 76.89B | 65.89B | 57.12B | 52.19B |
Cash Flow | ||||||
| Free Cash Flow | 16.09B | 14.73B | 15.86B | -14.60B | 8.22B | 11.66B |
| Operating Cash Flow | 29.91B | 29.83B | 31.68B | 6.70B | 19.71B | 22.40B |
| Investing Cash Flow | -15.93B | -20.06B | -16.75B | -22.56B | -11.11B | -10.25B |
| Financing Cash Flow | -8.13B | -7.92B | -8.17B | 9.03B | -5.18B | -7.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥93.71B | 8.94 | 9.07% | 3.61% | 9.39% | 77.24% | |
75 Outperform | ¥107.15B | 8.99 | 7.99% | 3.89% | 1.08% | 37.11% | |
74 Outperform | ¥76.61B | 19.04 | ― | 2.88% | 2.77% | 10.64% | |
73 Outperform | ¥459.75B | 28.19 | 6.03% | 1.81% | 7.08% | 43.50% | |
69 Neutral | ¥22.41B | -17.01 | ― | 2.18% | 6.66% | ― | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
62 Neutral | ¥44.04B | 11.82 | ― | 1.81% | 0.93% | 1212.45% |